mast cell stabilisation therapymidostaurinantihistaminesportal hypertensionSM-AHMchronic myelomonocytic leukaemia (CMML)
…agnosis of SM-AHM. The patient was treated with antihistamines, mast cell stabilisation therapy and midostaurin (a type III receptor tyrosine kinase inhibitor …